Regeneron Pharmaceuticals, Inc.
Time frame: 1 April 2023 - 31 March 2024Article ‘Count’ and ‘Share’ for Regeneron Pharmaceuticals, Inc. based on listed parameters only.
The articles listed below published by authors from Regeneron Pharmaceuticals, Inc., organized by journal and article, represent the research output in Count and Share according to the parameters selected above.
Journal | Count | Share |
---|---|---|
Cancer Cell |
2 | 0.17 |
Cancer Research |
2 | 0.08 |
Journal of Clinical Investigation |
1 | 0.07 |
Journal of Experimental Medicine |
1 | 0.09 |
Journal of Neuroscience |
1 | 0.08 |
Nature |
4 | 0.39 |
Nature Communications |
6 | 2.33 |
Nature Genetics |
5 | 1.60 |
Neuron |
1 | 0.03 |
PLOS Genetics |
1 | 1.00 |
Proceedings of the National Academy of Sciences of the United States of America |
2 | 1.94 |
Science Advances |
3 | 1.05 |
Science Translational Medicine |
2 | 0.92 |
![Creative Commons License](https://i.creativecommons.org/l/by-nc-sa/4.0/80x15.png)
Numerical information only is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.